Nam Kim Steel JSC (HOSE:NKG)

CTI BioPharma Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	522,553	391,784	785,479	1,005,404	751,446	219,162
Short-Term Investments	904,010	247,586	292,394	252,032	462,128	369,517
Trading Asset Securities	202,249	9.35	9.35	9.35	9.35	9.35
Cash & Short-Term Investments	1,628,812	639,379	1,077,882	1,257,444	1,213,583	588,688
Cash Growth	110.80%	-40.68%	-14.28%	3.61%	106.15%	-24.40%
Accounts Receivable	1,264,694	1,115,277	1,730,327	1,051,925	1,486,920	1,215,332
Other Receivables	23,642	14,677	8,649	10,563	1,919	10,385
Receivables	1,304,554	1,129,954	1,738,976	1,062,488	1,488,838	1,225,717
Inventory	6,127,101	6,690,483	5,718,699	7,000,417	8,281,324	2,371,077
Prepaid Expenses	29,785	29,406	16,586	16,774	13,523	9,213
Other Current Assets	1,431,345	1,713,148	770,495	1,077,785	1,218,330	297,568
Total Current Assets	10,521,597	10,202,371	9,322,639	10,414,909	12,215,599	4,492,265
Property, Plant & Equipment	4,565,543	1,986,074	2,338,487	2,525,066	2,705,823	2,936,121
Long-Term Investments	515,540	524,521	3,180	8,180	8,180	23,180
Other Intangible Assets	315,439	716,524	487,227	446,986	405,490	248,987
Long-Term Deferred Tax Assets	-	-	-	-	18,626	-
Other Long-Term Assets	561,270	89,597	83,868	65,619	44,197	62,540
Total Assets	16,479,389	13,519,086	12,235,401	13,460,760	15,397,915	7,763,093
Accounts Payable	1,608,628	855,939	1,631,419	2,544,341	4,879,072	1,070,444
Accrued Expenses	260,556	264,537	183,195	190,196	230,646	140,669
Short-Term Debt	-	-	-	-	-	2,498,488
Current Portion of Long-Term Debt	5,468,043	6,311,656	4,764,582	5,077,501	3,773,155	-
Current Portion of Leases	-	-	3,073	33,799	-	21,560
Current Income Taxes Payable	38,116	106,682	53,375	-	117,981	16,930
Other Current Liabilities	109,585	82,071	148,371	263,034	597,339	349,887
Total Current Liabilities	7,484,928	7,620,887	6,784,015	8,108,871	9,598,193	4,097,977
Long-Term Debt	1,388,814	-	-	-	46,499	457,252
Long-Term Leases	-	-	-	3,073	-	25,153
Long-Term Deferred Tax Liabilities	24,127	25,892	27,413	28,266	29,120	791.25
Other Long-Term Liabilities	900	900	900	900	900	900
Total Liabilities	8,898,770	7,647,679	6,812,327	8,141,110	9,674,712	4,582,073
Common Stock	4,475,709	3,159,320	2,632,778	2,632,778	2,183,986	1,819,999
Additional Paid-In Capital	522,371	259,366	785,907	785,907	785,907	766,256
Retained Earnings	2,484,039	2,363,281	1,917,297	1,813,873	2,710,724	636,128
Treasury Stock	-	-	-	-	-	-78,044
Comprehensive Income & Other	98,500	89,440	87,092	87,092	42,587	36,681
Total Common Equity	7,580,620	5,871,407	5,423,074	5,319,650	5,723,204	3,181,020
Shareholders' Equity	7,580,620	5,871,407	5,423,074	5,319,650	5,723,204	3,181,020
Total Liabilities & Equity	16,479,389	13,519,086	12,235,401	13,460,760	15,397,915	7,763,093
Total Debt	6,856,857	6,311,656	4,767,655	5,114,373	3,819,654	3,002,453
Net Cash (Debt)	-5,228,046	-5,672,277	-3,689,773	-3,856,928	-2,606,071	-2,413,765
Net Cash Per Share	-11680.93	-17954.11	-11679.01	-12210.48	-8514.58	-7872.19
Filing Date Shares Outstanding	447.57	447.57	315.93	315.93	314.49	297.22
Total Common Shares Outstanding	447.57	315.93	315.93	315.93	314.49	297.22
Working Capital	3,036,669	2,581,484	2,538,624	2,306,038	2,617,406	394,288
Book Value Per Share	16937.25	18584.40	17165.25	16837.89	18198.14	10702.73
Tangible Book Value	7,265,181	5,154,883	4,935,847	4,872,664	5,317,713	2,932,033
Tangible Book Value Per Share	16232.47	16316.43	15623.06	15423.08	16908.79	9865.00
Buildings	771,056	771,056	771,056	750,435	707,967	707,967
Machinery	4,217,512	4,312,293	4,240,600	4,175,680	4,121,336	3,928,900
Construction In Progress	3,010,281	285,776	311,996	219,721	176,007	58,576

Source: S&P Global Market Intelligence. Standard template. Financial Sources.